Dashboard
Manage Tickers

BPMC


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

expert-ratings-for-blueprint-medicines
Expert Ratings For Blueprint Medicines
06/28/2024 13:00:26

needham-reiterates-buy-on-blueprint-medicines-maintains-130-price-target
Needham Reiterates Buy on Blueprint Medici...
06/28/2024 10:15:02

Needham analyst Ami Fadia reiterates Blueprint Medicines (NASDAQ:BPMC) with a Buy and maintains $130 price target.

assessing-blueprint-medicines-insights-from-16-financial-analysts
Assessing Blueprint Medicines: Insights Fr...
06/07/2024 18:01:18

jmp-securities-reiterates-market-outperform-on-blueprint-medicines-maintains-125-price-target
JMP Securities Reiterates Market Outperfor...
06/07/2024 17:14:38

JMP Securities analyst Reni Benjamin reiterates Blueprint Medicines (NASDAQ:BPMC) with a Market Outperform and maintains $12...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
05/17/2024 17:35:23

unveiling-18-analyst-insights-on-blueprint-medicines
Unveiling 18 Analyst Insights On Blueprint...
05/14/2024 16:00:38

stephens--co-initiates-coverage-on-blueprint-medicines-with-overweight-rating-announces-price-target-of-140
Stephens & Co. Initiates Coverage On Bluep...
05/14/2024 09:58:30

Stephens & Co. analyst Sudan Loganathan initiates coverage on Blueprint Medicines (NASDAQ:BPMC) with a Overweight rating...

leerink-partners-upgrades-blueprint-medicines-to-market-perform-raises-price-target-to-97
Leerink Partners Upgrades Blueprint Medici...
05/06/2024 17:47:46

Leerink Partners analyst Andrew Berens upgrades Blueprint Medicines (NASDAQ:BPMC) from Underperform to Market Perform and ra...

goldman-sachs-maintains-buy-on-blueprint-medicines-raises-price-target-to-168
Goldman Sachs Maintains Buy on Blueprint M...
05/06/2024 15:17:15

Goldman Sachs analyst Terence Flynn maintains Blueprint Medicines (NASDAQ:BPMC) with a Buy and raises the price target from ...

citigroup-maintains-sell-on-blueprint-medicines-raises-price-target-to-76
Citigroup Maintains Sell on Blueprint Medi...
05/03/2024 21:55:28

Citigroup analyst David Lebowitz maintains Blueprint Medicines (NASDAQ:BPMC) with a Sell and raises the price target from $6...

hc-wainwright--co-maintains-buy-on-blueprint-medicines-raises-price-target-to-135
HC Wainwright & Co. Maintains Buy on Bluep...
05/03/2024 20:14:49

HC Wainwright & Co. analyst Andrew Fein maintains Blueprint Medicines (NASDAQ:BPMC) with a Buy and raises the price targ...

jmp-securities-maintains-market-outperform-on-blueprint-medicines-raises-price-target-to-125
JMP Securities Maintains Market Outperform...
05/03/2024 19:02:00

JMP Securities analyst Reni Benjamin maintains Blueprint Medicines (NASDAQ:BPMC) with a Market Outperform and raises the pri...

barclays-maintains-equal-weight-on-blueprint-medicines-raises-price-target-to-75
Barclays Maintains Equal-Weight on Bluepri...
05/03/2024 14:21:12

Barclays analyst Peter Lawson maintains Blueprint Medicines (NASDAQ:BPMC) with a Equal-Weight and raises the price target fr...

piper-sandler-maintains-neutral-on-blueprint-medicines-raises-price-target-to-104
Piper Sandler Maintains Neutral on Bluepri...
05/03/2024 13:44:51

Piper Sandler analyst Christopher Raymond maintains Blueprint Medicines (NASDAQ:BPMC) with a Neutral and raises the price ta...

needham-maintains-buy-on-blueprint-medicines-raises-price-target-to-130
Needham Maintains Buy on Blueprint Medicin...
05/03/2024 09:50:39

Needham analyst Ami Fadia maintains Blueprint Medicines (NASDAQ:BPMC) with a Buy and raises the price target from $97 to $130.

ch-robinson-worldwide-posts-upbeat-results-joins-avis-budget-group-qualcomm-borgwarner-moderna-and-other-big-stocks-moving-higher-on-thursday
C.H. Robinson Worldwide Posts Upbeat Resul...
05/02/2024 14:28:29

needham-reiterates-buy-on-blueprint-medicines-maintains-97-price-target
Needham Reiterates Buy on Blueprint Medici...
05/02/2024 11:54:23

Needham analyst Ami Fadia reiterates Blueprint Medicines (NASDAQ:BPMC) with a Buy and maintains $97 price target.

blueprint-medicines-corp-expects-2024-global-ayvakit-net-product-revenues-of-390m-410m-prior-360m-390m
Blueprint Medicines Corp Expects 2024 Glob...
05/02/2024 11:04:47

2024 Financial Guidance Blueprint Medicines now anticipates approximately $390 million to $410 million in global AYVAKIT net p...

blueprint-medicines-q1-2024-gaap-eps-140-beats-166-estimate-sales-96116m-beat-80434m-estimate
Blueprint Medicines Q1 2024 GAAP EPS $1.40...
05/02/2024 11:01:50

Blueprint Medicines (NASDAQ:BPMC) reported quarterly earnings of $1.40 per share which beat the analyst consensus estimate of $...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
05/01/2024 20:31:24

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)
07/16/2024 Teladoc Health, Inc. (TDOC)
07/16/2024 Vestis Corporation (VSTS)
07/22/2024 Cambium Networks Corporation (CMBM)
07/22/2024 Biogen Inc. (BIIB)
07/23/2024 Fastly, Inc. (FSLY)
07/29/2024 Enphase Energy, Inc. (ENPH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)